Disproportionately Increased Incidence of Anaplastic Thyroid Cancer in the North Yorkshire Region: A UK Tertiary Centre Study
- PMID: 39569306
- PMCID: PMC11577495
- DOI: 10.7759/cureus.72006
Disproportionately Increased Incidence of Anaplastic Thyroid Cancer in the North Yorkshire Region: A UK Tertiary Centre Study
Abstract
Globally, the incidence of anaplastic thyroid cancer (ATC) has followed a stable trend. However, over the past decade, we have observed a marked rise in the number of cases in the North Yorkshire region of the United Kingdom. Our study aimed to explore the incidence, demographics, and geographical distribution of ATC in this region over a 12-year period. We retrieved the clinical records of all patients with ATC in our centre from 2010 to 2022 and determined the incidence, demographics, and geographical spread of the data. 20 patients were diagnosed with ATC within the data collection period, with an average annual incidence of 14 per 10,000,000 of the entire North Yorkshire population (35 per 10,000,000 age-adjusted incidence rate). There was a clustering of data around the North Yorkshire region centre. The incidence of ATC in North Yorkshire was geometrically higher than the national average of 1.7 per 10,000,000. The geographical clustering around the region's centre was likely explained by its higher population density.
Keywords: anaplastic; cancer; dysphagia; head and neck surgery; neck lump; north yorkshire; thyroid; united kingdom.
Copyright © 2024, Adedeji et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Ethics committee of York Teaching Hospital issued approval (exempt). Since this was a retrospective study of patient case records with no alteration in interventions received by the patients nor involvement in clinical trials, approval with the exemption of patient consent was granted by the ethics committee of York Teaching Hospital. . Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


References
-
- Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal Maso L. Lancet Diabetes Endocrinol. 2021;9:225–234. - PubMed
-
- Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey. Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T. https://ar.iiarjournals.org/content/34/8/4439.short. Anticancer Res. 2014;34:4439–4445. - PubMed
-
- Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. N Engl J Med. 2016;375:614–617. - PubMed
-
- Thyroid cancer mortality and incidence: a global overview. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E. Int J Cancer. 2015;136:2187–2195. - PubMed
-
- The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. Lin B, Ma H, Ma M, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789224/ Am J Transl Res. 2019;11:5888–5896. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous